Marion Schauf

3PUBLICATIONS
9CO-AUTHORS
EndodonticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 30, 2026
The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price.

|Apr 14, 2026
Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis.

Jeanine Flanigan, Sarah Kane, Fatemeh Mirzayeh Fashami

|Nov 19, 2025
A budget impact model for biosimilar denosumab for skeletal-related events and fractures in the United States oncology population.

Jeanine Flanigan, Stephen Chaplin, Joris van Stiphout

Pageof 1